Home » GSK, Partner NPS Amend Pact to Add Stem Cell Research, Two Compounds
GSK, Partner NPS Amend Pact to Add Stem Cell Research, Two Compounds
GlaxoSmithKline will be able to take an osteoporosis compound in a new direction for possible use in stem cell transplants under a new deal with drug partner NPS Pharmaceuticals.
MedCity News
MedCity News
Upcoming Events
-
07May
-
14May
-
30May